This content is machine translated Myasthenia gravis: immunomodulatory therapies for long-term treatment Expanded Possibilities Thanks to Innovative Classes of Active Ingredients Myasthenic syndromes result from a disturbance in neuromuscular transmission. Although there is still no curative treatment for myasthenia gravis, the drug treatment options available today offer tailored therapeutic approaches aimed...…
View Post 2 min This content is machine translated Thrust-remitting MS An update on basic oral therapy Several encouraging advances have been made in the treatment of relapsing-remitting multiple sclerosis (MS) in recent years. Thus, the first orally administered substance – fingolimod – now also has a…
